This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Encounter, Patient, Practitioner |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicationRequest.
Generated Narrative: MedicationRequest
Resource MedicationRequest "medrx0306"
identifier: id: 12345689 (use: OFFICIAL)
status: active
intent: order
- | Reference |
* |
|
subject: Patient/pat1: Donald Duck "Donald DUCK"
authoredOn: 2015-01-15
requester: Practitioner/f007: Patrick Pump "Simone HEPS"
- | Concept |
* | Chronic myeloid Leukemia (disorder) (SNOMED CT#92818009) |
dosageInstruction
sequence: 1
text: 6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count. With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL
timing: Once per 1 days
route: Oral route (qualifier value) (SNOMED CT#26643006)
doseAndRate
Other examples that reference this example:
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.